Gilead Sciences Inc
(NASDAQ:GILD)
$75.27
0[0.00%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
$75.26
-0.0100[-0.01%]
Open-Close-
Vol / Avg.148.000 / 5.499MMkt Cap93.788B
Day Range- - -52 Wk Range61.445 - 89.610

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%

Gilead Sciences Stock (NASDAQ:GILD), Key Statistics

Gilead Sciences Stock (NASDAQ: GILD) analysis, key statistics.

Valuation Measures
Enterprise Value
112.4B
Trailing P/E
17.3
Forward P/E
10.29
PE Ratio (TTM)
11.22
PEG Ratio (TTM)
0.51
Price / Sales (ttm)
3.47
Price / Book (mrq)
4.43
Price / EBITDA
8.93
Enterprise Value / EBITDA (TTM)
10.56
Earnings Yield
5.78%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
16.98
Tangible Book value per share
-11.96
Total Liabilities (Quarterly)
41.2B
Total Assets
62.3B
Total Liabilities
- -
Profitability
Net income Growth
-0.09
Gross Margin
78.15%
Net Margin
15.84%
EBIT Margin
27.55%
EBITDA Margin
37.87%
Operating Margin
28.81%